Shares of G-III Apparel Group Ltd (GIII, Financial) fell 4.24% in mid-day trading on Oct 2. The stock reached an intraday low of $29.12, before recovering slightly to $29.16, down from its previous close of $30.45.
G-III Apparel Group, Ltd.'s Q2 2025 results were strong, with proprietary brands growing and improved margins, leading to raised yearly EPS guidance and a 30% stock price surge. The market reaction was exaggerated, but G-III Apparel Group's proprietary brands are growing by double digits, and the company continues to secure new licenses, like Converse. The company's operating margin improved, a...
NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- G-III Apparel Group, Ltd. (NasdaqGS: GIII) today reported results for the second quarter of fiscal 2025 ended July 31, 2024.
G-III Apparel Group, Ltd. was rated a “buy” in August 2023 despite disappointing financial performance. Shares have increased 28.9% since then, outperforming the S&P 500, with mixed financial results but attractive pricing. The company saw revenue decline in 2024, but profits and cash flows improved, inventory levels decreased, and strategic partnerships were made.
NEW YORK , Aug. 19, 2024 /PRNewswire/ -- In a bold move that captures the spirit of today's generation, DKNY announces that Kaia Gerber will continue as the face of the brand, bringing an authentic edge to the Fall 2024 Campaign. This past spring, DKNY began a new chapter, channeling iconic American style inspired by the New York energy that keeps the brand timeless.
NEW YORK , Aug. 15, 2024 /PRNewswire/ -- Continuing its iconic revival, Donna Karan New York unveils its Fall 2024 Campaign, "Reflections on Women," with a powerful message that celebrates the multi-faceted nature of modern women. This past spring, Donna Karan New York relaunched the brand with the "In Women We Trust" campaign, breathing new life into its story and legacy.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.